GlassScriptPhysician profile
Antonella Bianchi
NPI 1548379472
$708.92
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $411 · 2022: $298.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $104.52 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $72.25 | 2021-2022 | |
| Dexcom, INC. | $58.75 | 2021-2022 | |
| Insulet Corporation | $50.18 | 2021 | |
| Novo Nordisk INC | $48.21 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $43.82 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $41.20 | 2021-2022 | |
| Radius Health, INC. | $40.61 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.77 | 2021 | |
| Novartis Pharmaceuticals Corporation | $38.70 | 2022 | |
| Xeris Pharmaceuticals, INC. | $35.55 | 2021-2022 | |
| Recordati_rare_diseases_inc. | $22.71 | 2021 | |
| Antares Pharma, INC. | $22.54 | 2022 | |
| Lilly USA, LLC | $21.10 | 2021 | |
| Abbott Laboratories | $18.44 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $18.40 | 2022 | |
| Tandem Diabetes Care, INC. | $16.21 | 2021 | |
| Sanofi-Aventis U.S. LLC | $15.96 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonella Bianchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.